...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Stochs and MACD...looking bullish

I think it is definitely a failure when a company has to do financings on a weaker than warranted share price and subsequently experiences greater than needed dilution. I'd be willing to bet that even at $2.67 Hepalink feels they got a bargain basement price for their investment in RVX.

Share
New Message
Please login to post a reply